SCHEMBL21031240

SCHEMBL21031240

Cc1cc(-c2cccc(-c3ccccc3)c2)cc(-c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
ADORA1 P30542 4/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADORA2B P29275 1/20 0.46
RAB9A P51151 5/20 0.46
MAPT P10636 4/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
POLB P06746 1/20 0.46
PKM P14618 1/20 0.46
CYP19A1 P11511 1/20 0.46
NPC1 O15118 3/20 0.45
HPGD P15428 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TSHR P16473 1/20 0.44
ATM Q13315 1/20 0.44
ADORA2A P29274 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031241 0.98 MEN1 (0.56) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL21031238 0.96 MEN1 (0.49) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL19986167 0.96 MEN1 (0.49) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL21031239 0.94 MEN1 (0.51) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL13203397 0.94 MEN1 (0.51) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL316979 0.94 MEN1 (0.58) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL30928310 0.92 MEN1 (0.61) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL16373472 0.92 MEN1 (0.61) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL18538850 0.92 MEN1 (0.61) MEN1KMT2AADORA1ADORA3ADORA2B
SCHEMBL16376443 0.92 MEN1 (0.61) MEN1KMT2AADORA1ADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ADORA1 2991/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ADORA1 2991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.